• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多发性硬化症的自然史:一项包含部分纵向数据的区域研究。

The natural history of multiple sclerosis: a regional study with some longitudinal data.

作者信息

Miller D H, Hornabrook R W, Purdie G

机构信息

Department of Medicine, Wellington School of Medicine, University of Otago, Wellington Hospital, New Zealand.

出版信息

J Neurol Neurosurg Psychiatry. 1992 May;55(5):341-6. doi: 10.1136/jnnp.55.5.341.

DOI:10.1136/jnnp.55.5.341
PMID:1602305
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC489071/
Abstract

A regional survey of multiple sclerosis (MS) patients in Wellington, New Zealand in 1983 identified 245 patients, giving a prevalence (all categories included) of 72 per 100,000. Retrospective review of the history and medical records identified a poorer prognosis for disability where there was progressive onset of symptoms, secondary progression after a remitting phase, older age of onset (40 years or more), or a motor syndrome involving the limbs at presentation. In 1983 follow up data were obtained on 96 patients who were seen during a previous survey in 1968. For those with definite or probable MS, progression to severe disability (Kurtzke disability status scale (DSS) 6-9) or death (DSS 10) was seen in 26/34 with moderate disability (DSS 3-5) in 1968 and in only 5/29 with mild disability (DSS 0-2). When the analysis is confined to those with symptoms for at least five years in 1968, severe disability or death from MS occurred in 22/30 with moderate and 4/19 with mild disability (chi 2 = 10.8, p = 0.001). It is concluded that the patient's established disability level after five years of illness is a useful, but not infallible, prognostic indicator. From the follow up of the 1968 patients, the probability of MS-related mortality for a given disease duration was calculated. Using this survival distribution to adjust the disability ratings in the 1983 population, it was found that the proportion with mild disability decreased steadily with increasing disease duration, reaching 14% when the disease duration was more than 25 years.

摘要

1983年在新西兰惠灵顿对多发性硬化症(MS)患者进行的一项区域调查中,共识别出245例患者,患病率(包括所有类型)为每10万人中有72例。对病史和病历进行回顾性分析发现,症状呈渐进性发作、缓解期后出现继发进展、发病年龄较大(40岁及以上)或发病时出现累及四肢的运动综合征的患者,残疾预后较差。1983年,获取了96例在1968年之前的一次调查中见过的患者的随访数据。对于那些确诊或可能患有MS的患者,1968年时,34例中度残疾(Kurtzke残疾状态量表(DSS)3 - 5级)患者中有26例进展为严重残疾(DSS 6 - 9级)或死亡(DSS 10级),而29例轻度残疾(DSS 0 - 2级)患者中只有5例如此。当分析仅限于1968年出现症状至少5年的患者时,MS导致的严重残疾或死亡在30例中度残疾患者中有22例,19例轻度残疾患者中有4例(χ² = 10.8,p = 0.001)。得出的结论是,患病5年后患者已确定的残疾水平是一个有用但并非绝对可靠的预后指标。通过对1968年患者的随访,计算出了给定病程的MS相关死亡率。利用这种生存分布来调整1983年人群中的残疾评级,发现轻度残疾的比例随着病程延长而稳步下降,病程超过25年时降至14%。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/902e/489071/efc6b78737b5/jnnpsyc00490-0008-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/902e/489071/efc6b78737b5/jnnpsyc00490-0008-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/902e/489071/efc6b78737b5/jnnpsyc00490-0008-a.jpg

相似文献

1
The natural history of multiple sclerosis: a regional study with some longitudinal data.多发性硬化症的自然史:一项包含部分纵向数据的区域研究。
J Neurol Neurosurg Psychiatry. 1992 May;55(5):341-6. doi: 10.1136/jnnp.55.5.341.
2
The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis.多发性硬化症的自然史:一项基于地域的研究。5. 原发性进行性多发性硬化症的临床特征及自然史。
Brain. 1999 Apr;122 ( Pt 4):625-39. doi: 10.1093/brain/122.4.625.
3
The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability.多发性硬化症的自然史:一项基于地域的研究。I. 临床病程与残疾情况
Brain. 1989 Feb;112 ( Pt 1):133-46. doi: 10.1093/brain/112.1.133.
4
Disability and survival of multiple sclerosis in Saskatoon, Saskatchewan.萨斯喀彻温省萨斯卡通的多发性硬化症残疾和生存状况。
Can J Neurol Sci. 2010 Jan;37(1):28-35. doi: 10.1017/s0317167100009616.
5
Central Nervous System Idiopathic Inflammatory Demyelinating Disorders in South Americans: A Descriptive, Multicenter, Cross-Sectional Study.南美洲中枢神经系统特发性炎性脱髓鞘疾病:一项描述性、多中心、横断面研究。
PLoS One. 2015 Jul 29;10(7):e0127757. doi: 10.1371/journal.pone.0127757. eCollection 2015.
6
Age at disability milestones in multiple sclerosis.多发性硬化症中达到残疾里程碑的年龄。
Brain. 2006 Mar;129(Pt 3):595-605. doi: 10.1093/brain/awh714. Epub 2006 Jan 16.
7
Disability and mortality in a cohort of multiple sclerosis patients: a reappraisal.一组多发性硬化症患者的残疾与死亡率:重新评估
Neuroepidemiology. 2005;25(1):15-8. doi: 10.1159/000085308. Epub 2005 Apr 25.
8
Age and disability accumulation in multiple sclerosis.多发性硬化症中的年龄和残疾累积。
Neurology. 2011 Sep 27;77(13):1246-52. doi: 10.1212/WNL.0b013e318230a17d. Epub 2011 Sep 14.
9
Survival and predictors of disability in Turkish MS patients. Turkish Multiple Sclerosis Study Group (TUMSSG).土耳其多发性硬化症患者的生存率及残疾预测因素。土耳其多发性硬化症研究小组(TUMSSG)。
Neurology. 1998 Sep;51(3):765-72. doi: 10.1212/wnl.51.3.765.
10
Natural history of multiple sclerosis: a unifying concept.多发性硬化症的自然史:一个统一的概念。
Brain. 2006 Mar;129(Pt 3):606-16. doi: 10.1093/brain/awl007. Epub 2006 Jan 16.

引用本文的文献

1
Longitudinal accumulation of glial activation measured by TSPO-PET predicts later brain atrophy in multiple sclerosis.通过TSPO-PET测量的胶质细胞激活的纵向积累可预测多发性硬化症患者后期的脑萎缩。
J Neuroinflammation. 2025 Aug 7;22(1):200. doi: 10.1186/s12974-025-03519-y.
2
The prevalence of multiple sclerosis (MS) in Oceania, a systematic review, and meta-analysis.大洋洲多发性硬化症(MS)的患病率:系统评价和荟萃分析。
Neurol Sci. 2024 Jan;45(1):75-82. doi: 10.1007/s10072-023-07057-4. Epub 2023 Sep 8.
3
Regional Cerebellar Volume Loss Predicts Future Disability in Multiple Sclerosis Patients.

本文引用的文献

1
The benign form of multiple sclerosis. A study based on 241 cases seen within three years of onset and followed up until the tenth year or more of the disease.多发性硬化症的良性型。一项基于发病三年内确诊的241例病例,并随访至疾病第十年或更久的研究。
Brain. 1961 Jun;84:186-203. doi: 10.1093/brain/84.2.186.
2
On the evaluation of disability in multiple sclerosis.关于多发性硬化症残疾情况的评估。
Neurology. 1961 Aug;11:686-94. doi: 10.1212/wnl.11.8.686.
3
Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients.
小脑区域性容积损失可预测多发性硬化症患者的未来残疾。
Cerebellum. 2022 Aug;21(4):632-646. doi: 10.1007/s12311-021-01312-0. Epub 2021 Aug 21.
4
Early High Efficacy Treatment in Multiple Sclerosis Is the Best Predictor of Future Disease Activity Over 1 and 2 Years in a Norwegian Population-Based Registry.在挪威基于人群的登记研究中,多发性硬化症的早期高效治疗是未来1年和2年疾病活动的最佳预测指标。
Front Neurol. 2021 Jun 17;12:693017. doi: 10.3389/fneur.2021.693017. eCollection 2021.
5
Meningeal inflammation in multiple sclerosis induces phenotypic changes in cortical microglia that differentially associate with neurodegeneration.多发性硬化症中的脑膜炎症会引起皮质小胶质细胞表型的变化,这些变化与神经退行性变有不同的关联。
Acta Neuropathol. 2021 Jun;141(6):881-899. doi: 10.1007/s00401-021-02293-4. Epub 2021 Mar 29.
6
The role of the cerebellum in multiple sclerosis.小脑在多发性硬化症中的作用。
Cerebellum. 2015 Jun;14(3):364-74. doi: 10.1007/s12311-014-0634-8.
7
Cerebellar abnormalities contribute to disability including cognitive impairment in multiple sclerosis.小脑异常会导致包括多发性硬化症认知障碍在内的残疾。
PLoS One. 2014 Jan 22;9(1):e86916. doi: 10.1371/journal.pone.0086916. eCollection 2014.
8
Evaluation of a new approach for semi-automatic segmentation of the cerebellum in patients with multiple sclerosis.评估一种新的用于多发性硬化症患者小脑半自动分割的方法。
J Neurol. 2012 Dec;259(12):2673-80. doi: 10.1007/s00415-012-6569-4. Epub 2012 Jun 19.
9
Clinical prognostic factors in multiple sclerosis: a natural history review.多发性硬化症的临床预后因素:自然病史回顾。
Nat Rev Neurol. 2009 Dec;5(12):672-82. doi: 10.1038/nrneurol.2009.178.
10
Predicting responders to therapies for multiple sclerosis.预测多发性硬化症治疗的反应者。
Nat Rev Neurol. 2009 Oct;5(10):553-60. doi: 10.1038/nrneurol.2009.139.
通过对349例患者的计算机数据处理评估多发性硬化症的病程和预后。
Brain. 1980 Jun;103(2):281-300. doi: 10.1093/brain/103.2.281.
4
Age at onset, initial symptomatology and the course of multiple sclerosis.多发性硬化症的发病年龄、初始症状及病程。
Acta Neurol Scand. 1982 Sep;66(3):355-62. doi: 10.1111/j.1600-0404.1982.tb06856.x.
5
Prognosis of multiple sclerosis. Results from an epidemiological area in Germany.多发性硬化症的预后。德国某流行病学区域的研究结果。
Acta Neurol Scand. 1982 Apr;65(4):347-54. doi: 10.1111/j.1600-0404.1982.tb03091.x.
6
Onset symptoms as predictors of mortality and disability in multiple sclerosis.首发症状作为多发性硬化症死亡率和残疾率的预测指标
Acta Neurol Scand. 1984 Nov;70(5):321-8. doi: 10.1111/j.1600-0404.1984.tb00832.x.
7
Survival and death in multiple sclerosis.多发性硬化症中的生存与死亡
Brain. 1969 Mar;92(1):115-30. doi: 10.1093/brain/92.1.115.
8
Survival in multiple sclerosis.多发性硬化症的生存情况。
Trans Am Neurol Assoc. 1969;94:134-9.
9
The prevalence of multiple sclerosis in New Zealand.新西兰多发性硬化症的患病率。
Acta Neurol Scand. 1971;47(4):426-38. doi: 10.1111/j.1600-0404.1971.tb07497.x.
10
Survival pattern and cause of death in patients with multiple sclerosis: results from an epidemiological survey in north east Scotland.多发性硬化症患者的生存模式及死因:苏格兰东北部一项流行病学调查的结果
J Neurol Neurosurg Psychiatry. 1987 May;50(5):523-31. doi: 10.1136/jnnp.50.5.523.